+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cellulite Treatment Market by Type, Procedure Type, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011257
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cellulite Treatment Market grew from USD 3.58 billion in 2023 to USD 3.91 billion in 2024. It is expected to continue growing at a CAGR of 9.59%, reaching USD 6.81 billion by 2030.

The cellulite treatment market is defined by its focus on products and procedures designed to reduce the appearance of cellulite, a common skin condition characterized by dimpled skin largely observed in women. This market encompasses a variety of treatment methods, including topical treatments, non-invasive procedures like laser therapy and radiofrequency, and minimally invasive techniques such as subcision and dermal fillers. The necessity for cellulite treatment is driven by rising aesthetic consciousness and the growing desire for improved skin appearance among consumers. The application extends from at-home topical creams to clinical and spa-based body contouring procedures, with dermatology and wellness centers being the primary end-use domains. Key growth influencers include advancements in aesthetic technology, increasing disposable incomes, and an aging population seeking anti-aging solutions.

The market is witnessing substantial opportunities due to innovations in treatment methods, particularly non-invasive techniques that promise minimal downtime. Growing consumer demand for natural and organic products also presents an opportunity for product differentiation in topical treatments. However, market growth is hindered by high costs of advanced treatments, varying regulatory standards across regions, and skepticism regarding the efficacy of some treatments. Research and development are ripe for innovation, particularly in creating more effective, affordable, and long-lasting solutions. Emphasis on personalized treatment regimens using AI and big data could further enhance market offerings. The market is characterized by fierce competition and rapid technological advancements, necessitating constant innovation to stay ahead.

Strategically, companies are recommended to focus on expanding their portfolio of non-invasive treatments and enhancing customer engagement through digital channels. Ensuring compliance with regulatory frameworks and investing in clinical trials to validate treatment efficacy can enhance consumer trust. Additionally, partnerships with skincare brands and wellness centers can facilitate wider reach and brand recognition. Overall, prioritizing R&D, leveraging unique delivery systems, and fostering educational initiatives to heighten consumer awareness about available treatments are pivotal for navigating the competitive landscape of the cellulite treatment market.

Understanding Market Dynamics in the Cellulite Treatment Market

The Cellulite Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rise in the prevalence of obesity
    • Increasing consumer focus on physical appearance
    • Popularity of minimally invasive procedures among consumers
  • Market Restraints
    • Limited awareness and accessibility of cellulite treatments
  • Market Opportunities
    • Development of topical anti-cellulite creams and radiofrequency therapy
    • Medical tourism in economies delivering affordable aesthetic surgical procedures
  • Market Challenges
    • Possible side effects of surgeries and procedures

Exploring Porter’s Five Forces for the Cellulite Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Cellulite Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cellulite Treatment Market

External macro-environmental factors deeply influence the performance of the Cellulite Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cellulite Treatment Market

The Cellulite Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cellulite Treatment Market

The Cellulite Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cellulite Treatment Market

The Cellulite Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cellulite Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Alma Lasers Ltd., Beijing Sincoheren S & T Development Co., Ltd., Candela Corporation, Cutera, Inc., Cymedics, Cymedics GmbH & Co. KG, Cynosure, Inc., Endo-Systems LLC, Hologic Inc., Inceler Medikal Co. Ltd., Johnson & Johnson Services, Inc., Merz Pharma, Merz Pharma GmbH & Co. KGaA, Nestle S.A., Shanghai Fosun Pharmaceutical (Group) Co. Ltd, Skinrex Co., Ltd., Venus Concept Inc., and Zimmer Aesthetics, Inc..

Market Segmentation & Coverage

This research report categorizes the Cellulite Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Edematous Cellulite
    • Hard Cellulite
    • Soft Cellulite
  • Procedure Type
    • Minimally Invasive
    • Non-Invasive
    • Topical
  • End-Use
    • Cosmetic Surgery Centers
    • Dermatology Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of obesity
5.1.1.2. Increasing consumer focus on physical appearance
5.1.1.3. Popularity of minimally invasive procedures among consumers
5.1.2. Restraints
5.1.2.1. Limited awareness and accessibility of cellulite treatments
5.1.3. Opportunities
5.1.3.1. Development of topical anti-cellulite creams and radiofrequency therapy
5.1.3.2. Medical tourism in economies delivering affordable aesthetic surgical procedures
5.1.4. Challenges
5.1.4.1. Possible side effects of surgeries and procedures
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cellulite Treatment Market, by Type
6.1. Introduction
6.2. Edematous Cellulite
6.3. Hard Cellulite
6.4. Soft Cellulite
7. Cellulite Treatment Market, by Procedure Type
7.1. Introduction
7.2. Minimally Invasive
7.3. Non-Invasive
7.4. Topical
8. Cellulite Treatment Market, by End-Use
8.1. Introduction
8.2. Cosmetic Surgery Centers
8.3. Dermatology Clinics
8.4. Hospitals
9. Americas Cellulite Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cellulite Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cellulite Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CELLULITE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. CELLULITE TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CELLULITE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELLULITE TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY EDEMATOUS CELLULITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HARD CELLULITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY SOFT CELLULITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COSMETIC SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. CANADA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. CHINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. INDIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. ITALY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. POLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. QATAR CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cellulite Treatment market, which are profiled in this report, include:
  • AbbVie, Inc.
  • Alma Lasers Ltd.
  • Beijing Sincoheren S & T Development Co., Ltd.
  • Candela Corporation
  • Cutera, Inc.
  • Cymedics
  • Cymedics GmbH & Co. KG
  • Cynosure, Inc.
  • Endo-Systems LLC
  • Hologic Inc.
  • Inceler Medikal Co. Ltd.
  • Johnson & Johnson Services, Inc.
  • Merz Pharma
  • Merz Pharma GmbH & Co. KGaA
  • Nestle S.A.
  • Shanghai Fosun Pharmaceutical (Group) Co. Ltd
  • Skinrex Co., Ltd.
  • Venus Concept Inc.
  • Zimmer Aesthetics, Inc.

Methodology

Loading
LOADING...

Table Information